Advances in the conventional clinical treatment for hepatoblastoma and therapeutic innovation
{{output}}
Background: Hepatoblastoma (HB) is a rare malignancy usually occurring in children under 3 years old. With advancements in surgical techniques and molecular biology, new treatments have been developed. ... ...
